SCHEMBL1227358

SCHEMBL1227358

COc1ccc(CN2C(=O)C(=Cc3ccc(-c4ccc(OC)c(Cl)c4)o3)N=C2N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.50
▸ ALDH1A1 P00352 6/20 0.50
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ POLB P06746 5/20 0.50
▸ MCL1 Q07820 3/20 0.50
▸ NPSR1 Q6W5P4 2/20 0.50
▸ PKM P14618 2/20 0.50
▸ PTPN7 P35236 1/20 0.50
▸ PTPN12 Q05209 1/20 0.50
▸ PTPN22 Q9Y2R2 1/20 0.50
▸ HTRA2 O43464 1/20 0.49
▸ KDM4E B2RXH2 2/20 0.42
▸ RECQL P46063 4/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ DNMT1 P26358 2/20 0.42
▸ APEX1 P27695 2/20 0.42
▸ PLA2G1B P04054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1227354 1.00 MAPT (0.50) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228154 0.94 HTRA2 (0.49) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228155 0.94 HTRA2 (0.49) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228307 0.92 HTRA2 (0.47) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228304 0.92 HTRA2 (0.47) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1116263 0.92 HTRA2 (0.57) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1116267 0.92 HTRA2 (0.57) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228294 0.91 HTRA2 (0.49) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228296 0.91 HTRA2 (0.49) MAPTALDH1A1MEN1KMT2APOLB
SCHEMBL1228130 0.91 HTRA2 (0.50) MAPTALDH1A1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
Send feedback